Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

Genprex, Inc.

Genprex develops gene therapies for patients with cancer and diabetes, aimed at providing new treatment options for those with limited alternatives.

COM:GENPREX

Genprex

Last Close

0.47

14/02 21:00

Market Cap

3.88M

Beta: -

Volume Today

1.45M

Avg: -

People Not Available